reference/15875819

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15875819

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	455
issn	0021-9738
issueIdentifier	4
pageRange	449-455
publicationName	The Journal of clinical investigation
startingPage	449
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_be82f5ff765329dcad80facd6b3da339 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6d059993728b877f5e97f9264cb5f4b5
bibliographicCitation	Ono SK, Kato N, Shiratori Y, Kato J, Goto T, Schinazi RF, Carrilho FJ, Omata M. The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. J Clin Invest. 2001 Feb;107(4):449–55. PMID: 11181644; PMCID: PMC199250.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4599b5a0bf0f0423c2cb64f0f38aa23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a43fd35c260f3a6c6d67b4918fd9730 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e3f0de005792ccfc3d6ac825b51d4dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04494d28da9ace0bc4211e5b67bca42f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a98b135c94369d5569fa2045bb51a1e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68a5e47c2ce466390a9e9dce983ae052 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c5aa643aaab28e64ecda6d375cf1df7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae074c9352803158a05af8acdc451276
date	2001-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC199250 https://pubmed.ncbi.nlm.nih.gov/11181644 https://doi.org/10.1172/jci11100
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4632 https://portal.issn.org/resource/ISSN/0021-9738
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance
discusses	http://id.nlm.nih.gov/mesh/M0018988 http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0015075
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006515Q000187 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D000998Q000494 http://id.nlm.nih.gov/mesh/D014779 http://id.nlm.nih.gov/mesh/D012194Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002478 http://id.nlm.nih.gov/mesh/D006515Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004351 http://id.nlm.nih.gov/mesh/D006515Q000201 http://id.nlm.nih.gov/mesh/D001665 http://id.nlm.nih.gov/mesh/D009711Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73115 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9837769 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398508 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID454858 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60877 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124088 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID469717 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135433604 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73339

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136262261 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129613204

Total number of triples: 60.